Skip to main content
  • EN
  • FI
  • SV
Login

Main navigation

  • About FinnGen
    • Summary & Goals
      • Goals
      • FinnGen 1-2
      • FinnGen 3 (2023-2027)
    • Consortium
      • Partners
      • Funding
      • Governance
      • Steering Committee Members
      • Scientific Committee Members
      • Teams
      • Collaboration
    • Impact
      • National Impact
      • National Research Network
      • Open Science
      • Research Highlights
    • Why Finland?
      • Biobank Network
      • Legislative Review
      • National Registries
      • Population Genetic History
      • Industry partners
    • Mediabank
  • For Researchers
    • Research Activities
      • Core Analyses
      • Disease Task Forces
      • Expansion Areas
      • Global Initiatives
    • Cohort and Data
      • Register Data
      • Basic Characteristics
      • Clinical Endpoints
      • Genetic Data
      • Laboratory Values
      • Other Phenotype Data
      • Recruitment
      • Other Biological Data
      • Data Available
    • Accessing Data, Results & Tools
      • Access results
      • Computing environment
      • How we collaborate
      • Partner researchers
      • Public data releases
      • Tools
    • Publications
    • Researcher FAQ
  • For Participants
    • Participation
      • Study Participants
      • Biobanks' Role in FinnGen
      • Biobank Contact Information
      • Recall Studies
      • Questions and answers
    • Data Protection and Security
      • Data Protection
      • Data Security
      • Sample & Data Flow
      • Data Protection Statement
    • Significance
      • Videos
  • News
  • EN
  • FI
  • SV

Links

  • PheWeb
  • Risteys
  • Meta-analysis Pheweb (FG-MVP-UKBB)
  • FinnGen handbook
  • Meta-analysis Pheweb (FG-UKBB)
  • Coding variant browser
  • Endpoint Browser
  • FinnGen GITHUB
  • LAVAA volcano plot
  • Multiple Manhattan Plot
  • Variant Cluster Corrector
  • Variant Cluster Call Corrector
Breadcrumb
  1. Home
  2. Node

Multi-Omics Prioritization and Clinical Evaluation of CYP4V2 as a Candidate Biomarker in Venous Thromboembolism

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/26/2026 - 10:41
  • Read more about Multi-Omics Prioritization and Clinical Evaluation of CYP4V2 as a Candidate Biomarker in Venous Thromboembolism

Causal Effects of Inflammatory Proteins and Metabolites on Skin Soft Tissue Infections: Mendelian Randomization and Mediation Analysis

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/26/2026 - 10:41
  • Read more about Causal Effects of Inflammatory Proteins and Metabolites on Skin Soft Tissue Infections: Mendelian Randomization and Mediation Analysis

Exome-wide association study reveals common and rare coding variants shaping chronic pain in 327,642 UK biobank participants

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/26/2026 - 10:40
  • Read more about Exome-wide association study reveals common and rare coding variants shaping chronic pain in 327,642 UK biobank participants

Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two-Sample Mendelian Randomization Study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/26/2026 - 10:39
  • Read more about Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two-Sample Mendelian Randomization Study

Association between malocclusion and temporomandibular joint disorders: evidence from a Mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/26/2026 - 10:36
  • Read more about Association between malocclusion and temporomandibular joint disorders: evidence from a Mendelian randomization study

Exome-wide rare variant genetic load is associated with cognition, intellectual disability and psychiatric disorders in population-based cohorts

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 10/20/2026 - 13:04
  • Read more about Exome-wide rare variant genetic load is associated with cognition, intellectual disability and psychiatric disorders in population-based cohorts

Short telomeres, but not accelerated epigenetic or proteomic age, increase fibrotic lung disease risk: Mendelian randomisation with pleiotropy dissection and independent replication

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 10/20/2026 - 13:02
  • Read more about Short telomeres, but not accelerated epigenetic or proteomic age, increase fibrotic lung disease risk: Mendelian randomisation with pleiotropy dissection and independent replication

Hepatocyte UBE4A protects against MASLD and MASH by maintaining ER homeostasis via UBXN4 interaction

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 10/20/2026 - 12:59
  • Read more about Hepatocyte UBE4A protects against MASLD and MASH by maintaining ER homeostasis via UBXN4 interaction

Common centromeric variation associates with molecular and complex traits in humans

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Tue, 10/20/2026 - 12:56
  • Read more about Common centromeric variation associates with molecular and complex traits in humans

Genetically proxied sex hormones, Sjögren's disease, and broad dry eye disease: A bidirectional two-sample mendelian randomization study

Profile picture for user Anna Hakala
Submitted by Anna Hakala on Mon, 10/19/2026 - 11:25
  • Read more about Genetically proxied sex hormones, Sjögren's disease, and broad dry eye disease: A bidirectional two-sample mendelian randomization study

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Current page 13
  • Page 14
  • Page 15
  • Page 16
  • Page 17
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Contact us

Contact person
finngen-info@helsinki.fi
Follow us on Bluesky
@finngen.bsky.social
Follow us on LinkedIn
https://www.linkedin.com/company/finngen/

Lead organisations

The University of Helsinki is the organization responsible for the FinnGen research project. The Finnish consortium partners include all Finnish public biobanks and their background organisations, so the project covers the whole of Finland. All partners are listed on this page.

About the website

Accessibility statement